We developed a CNN-based prediction model for patient-specific QA of dose distribution in prostate treatment. Our results suggest that deep learning may provide a useful prediction model for gamma evaluation of patient-specific QA in prostate treatment planning.
By means of the magnetocaloric effect, we examine the nature of the superconducting-normal (S-N) transition of Sr(2)RuO(4), a most promising candidate for a spin-triplet superconductor. We provide thermodynamic evidence that the S-N transition of this oxide is of first order below approximately 0.8 K and only for magnetic field directions very close to the conducting plane, in clear contrast to the ordinary type-II superconductors exhibiting second-order S-N transitions. The entropy release across the transition at 0.2 K is 10% of the normal-state entropy. Our result urges an introduction of a new mechanism to break superconductivity by magnetic field.
We investigate the specific heat of ultra-pure single crystals of Sr 2 RuO 4 , a leading candidate of a spin-triplet superconductor. We for the first time obtained specific-heat evidence of the first-order superconducting transition below 0.8 K, namely divergent-like peaks and clear hysteresis in the specific heat at the upper critical field. The first-order transition occurs for all in-plane field directions. The specific-heat features for the first-order transition are found to be highly sensitive to sample quality; in particular, the hysteresis becomes totally absent in a sample with slightly lower quality. These thermodynamic observations provide crucial bases to understand the unconventional pair-breaking effect responsible for the first-order transition.
The purpose of the study was to compare a 3D convolutional neural network (CNN) with the conventional machine learning method for predicting intensity-modulated radiation therapy (IMRT) dose distribution using only contours in prostate cancer. In this study, which included 95 IMRT-treated prostate cancer patients with available dose distributions and contours for planning target volume (PTVs) and organs at risk (OARs), a supervised-learning approach was used for training, where the dose for a voxel set in the dataset was defined as the label. The adaptive moment estimation algorithm was employed for optimizing a 3D U-net similar network. Eighty cases were used for the training and validation set in 5-fold cross-validation, and the remaining 15 cases were used as the test set. The predicted dose distributions were compared with the clinical dose distributions, and the model performance was evaluated by comparison with RapidPlan™. Dose–volume histogram (DVH) parameters were calculated for each contour as evaluation indexes. The mean absolute errors (MAE) with one standard deviation (1SD) between the clinical and CNN-predicted doses were 1.10% ± 0.64%, 2.50% ± 1.17%, 2.04% ± 1.40%, and 2.08% ± 1.99% for D2, D98 in PTV-1 and V65 in rectum and V65 in bladder, respectively, whereas the MAEs with 1SD between the clinical and the RapidPlan™-generated doses were 1.01% ± 0.66%, 2.15% ± 1.25%, 5.34% ± 2.13% and 3.04% ± 1.79%, respectively. Our CNN model could predict dose distributions that were superior or comparable with that generated by RapidPlan™, suggesting the potential of CNN in dose distribution prediction.
Purpose This study aimed to develop and evaluate a novel strategy for establishing a deep learning‐based gamma passing rate (GPR) prediction model for volumetric modulated arc therapy (VMAT) using dummy target plan data, one measurement process, and a multicriteria prediction method. Methods A total of 147 VMAT plans were used for the training set (two sets of 48 dummy target plans) and test set (51 clinical target plans). The dummy plans were measured using a diode array detector. We developed an original convolutional neural network that accepts coronal and sagittal dose distributions to predict the GPRs of 36 pairs of gamma criteria from 0.5%/0.5 mm to 3%/3 mm. Sixfold cross‐validation and model averaging were performed, and the mean training result and mean test result were derived from six trained models that were produced during cross‐validation. Results Strong or moderate correlations were observed between the measured and predicted GPRs in all criteria. The mean absolute errors and root mean squared errors of the test set (clinical target plan) were 0.63 and 1.11 in 3%/3 mm, 1.16 and 1.73 in 3%/2 mm, 1.96 and 2.66 in 2%/2 mm, 5.00 and 6.35 in 1%/1 mm, and 5.42 and 6.78 in 0.5%/1 mm, respectively. The Pearson correlation coefficients were 0.80 in the training set and 0.68 in the test set at the 0.5%/1 mm criterion. Conclusion Our results suggest that the training of the deep learning‐based quality assurance model can be performed using a dummy target plan.
Purpose: Radiomics is a new technique that enables noninvasive prognostic prediction by extracting features from medical images. Homology is a concept used in many branches of algebra and topology that can quantify the contact degree. In the present study, we developed homology-based radiomic features to predict the prognosis of non-small-cell lung cancer (NSCLC) patients and then evaluated the accuracy of this prediction method. Methods: Four datasets were used: two to provide training and test data and two for the selection of robust radiomic features. All the datasets were downloaded from The Cancer Imaging Archive (TCIA). In two-dimensional cases, the Betti numbers consist of two values: b 0 (zero-dimensional Betti number), which is the number of isolated components, and b 1 (one-dimensional Betti number), which is the number of one-dimensional or "circular" holes. For homology-based evaluation, computed tomography (CT) images must be converted to binarized images in which each pixel has two possible values: 0 or 1. All CT slices of the gross tumor volume were used for calculating the homology histogram. First, by changing the threshold of the CT value (range: À150 to 300 HU) for all its slices, we developed homology-based histograms for b 0 , b 1 , and b 1 /b 0 using binarized images. All histograms were then summed, and the summed histogram was normalized by the number of slices. 144 homology-based radiomic features were defined from the histogram. To compare the standard radiomic features, 107 radiomic features were calculated using the standard radiomics technique.To clarify the prognostic power, the relationship between the values of the homology-based radiomic features and overall survival was evaluated using LASSO Cox regression model and the Kaplan-Meier method. The retained features with nonzero coefficients calculated by the LASSO Cox regression model were used for fitting the regression model. Moreover, these features were then integrated into a radiomics signature. An individualized rad score was calculated from a linear combination of the selected features, which were weighted by their respective coefficients. Results: When the patients in the training and test datasets were stratified into high-risk and low-risk groups according to the rad scores, the overall survival of the groups was significantly different. The C-index values for the homology-based features (rad score), standard features (rad score), and tumor size were 0.625, 0.603, and 0.607, respectively, for the training datasets and 0.689, 0.668, and 0.667 for the test datasets. This result showed that homology-based radiomic features had slightly higher prediction power than the standard radiomic features. Conclusions: Prediction performance using homology-based radiomic features had a comparable or slightly higher prediction power than standard radiomic features. These findings suggest that homology-based radiomic features may have great potential for improving the prognostic prediction accuracy of CT-based radiomics. In this result, i...
Purpose In patient‐specific quality assurance (QA) for static beam intensity‐modulated radiation therapy (IMRT), machine‐learning‐based dose analysis methods have been developed to identify the cause of an error as an alternative to gamma analysis. Although these new methods have revealed that the cause of the error can be identified by analyzing the dose distribution obtained from the two‐dimensional detector, they have not been extended to the analysis of volumetric‐modulated arc therapy (VMAT) QA. In this study, we propose a deep learning approach to detect various types of errors in patient‐specific VMAT QA. Methods A total of 161 beams from 104 prostate VMAT plans were analyzed. All beams were measured using a cylindrical detector (Delta4; ScandiDos, Uppsala, Sweden), and predicted dose distributions in a cylindrical phantom were calculated using a treatment planning system (TPS). In addition to the error‐free plan, we simulated 12 types of errors: two types of multileaf collimator positional errors (systematic or random leaf offset of 2 mm), two types of monitor unit (MU) scaling errors (±3%), two types of gantry rotation errors (±2° in clockwise and counterclockwise direction), and six types of phantom setup errors (±1 mm in lateral, longitudinal, and vertical directions). The error‐introduced predicted dose distributions were created by editing the calculated dose distributions using a TPS with in‐house software. Those 13 types of dose difference maps, consisting of an error‐free map and 12 error maps, were created from the measured and predicted dose distributions and were used to train the convolutional neural network (CNN) model. Our model was a multi‐task model that individually detected each of the 12 types of errors. Two datasets, Test sets 1 and 2, were prepared to evaluate the performance of the model. Test set 1 consisted of 13 types of dose maps used for training, whereas Test set 2 included the dose maps with 25 types of errors in addition to the error‐free dose map. The dose map, which introduced 25 types of errors, was generated by combining two of the 12 types of simulated errors. For comparison with the performance of our model, gamma analysis was performed for Test sets 1 and 2 with the criteria set to 3%/2 mm and 2%/1 mm (dose difference/distance to agreement). Results For Test set 1, the overall accuracy of our CNN model, gamma analysis with the criteria set to 3%/2 mm, and gamma analysis with the criteria set to 2%/1 mm was 0.92, 0.19, and 0.81, respectively. Similarly, for Test set 2, the overall accuracy was 0.44, 0.42, and 0.95, respectively. Our model outperformed gamma analysis in the classification of dose maps containing a single type error, and the performance of our model was inferior in the classification of dose maps containing compound errors. Conclusions A multi‐task CNN model for detecting errors in patient‐specific VMAT QA using a cylindrical measuring device was constructed, and its performance was evaluated. Our results demonstrate that our model was effective ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.